TE
Tema ETFs Portfolio holdings
AUM
$377M
This Quarter Return
+13.47%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$377M
AUM Growth
+$41.9M
(+13%)
Cap. Flow
+$8.19M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
20.9%
Holding
176
New
29
Increased
67
Reduced
61
Closed
11
Top Buys
| 1 |
Eaton
ETN
|
$10M |
| 2 |
Cognex
CGNX
|
$7.72M |
| 3 |
CRH
CRH
|
$5.63M |
| 4 |
Linde
LIN
|
$5.21M |
| 5 |
Johnson Controls International
JCI
|
$3.81M |
Top Sells
| 1 |
Vulcan Materials
VMC
|
$5.25M |
| 2 |
APi Group
APG
|
$4.9M |
| 3 |
Rockwell Automation
ROK
|
$4.88M |
| 4 |
Clean Harbors
CLH
|
$4.34M |
| 5 |
Applied Industrial Technologies
AIT
|
$3.95M |
Sector Composition
| 1 | Industrials | 38.16% |
| 2 | Healthcare | 30.66% |
| 3 | Technology | 10.25% |
| 4 | Utilities | 8.88% |
| 5 | Materials | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Biogen
BIIB
$20.5B
| $315K | 0.08% |
2,511
+10
| +0.4% | +$1.26K |
|
|
MREO
152
Mereo BioPharma
MREO
$269M
| $278K | 0.07% |
102,583
-552,083
| -84% | -$1.5M |
|
|
AUTL
153
Autolus Therapeutics
AUTL
$378M
| $274K | 0.07% |
120,388
+9,960
| +9% | +$22.7K |
|
154
Nuvation Bio
NUVB
$1.11B
| $272K | 0.07% |
+139,648
| New | +$272K |
|
155
AnaptysBio
ANAB
$632M
| $253K | 0.07% |
+11,404
| New | +$253K |
|
156
Catalyst Pharmaceutical
CPRX
$2.4B
| $246K | 0.07% |
11,352
| – | – |
|
157
Axsome Therapeutics
AXSM
$6.11B
| $243K | 0.06% |
2,327
| – | – |
|
158
Ferrari
RACE
$88.5B
| $230K | 0.06% |
+469
| New | +$230K |
|
159
Acadia Pharmaceuticals
ACAD
$4.27B
| $229K | 0.06% |
10,596
| – | – |
|
160
Celcuity
CELC
$2.31B
| $227K | 0.06% |
17,011
+1,392
| +9% | +$18.6K |
|
161
Intellia Therapeutics
NTLA
$1.23B
| $226K | 0.06% |
24,053
-2,484
| -9% | -$23.3K |
|
162
Denali Therapeutics
DNLI
$2.18B
| $212K | 0.06% |
15,174
| – | – |
|
163
Rocket Pharmaceuticals
RCKT
$351M
| $78.5K | 0.02% |
32,030
-4,833
| -13% | -$11.8K |
|
164
Talkspace
TALK
$439M
| $77.4K | 0.02% |
27,834
| – | – |
|
165
Voyager Therapeutics
VYGR
$202M
| $46.5K | 0.01% |
14,960
| – | – |
|
166
Analog Devices
ADI
$118B
| – | – |
-4,664
| Closed | -$941K |
|
|
BPMC
167
DELISTED
Blueprint Medicines
BPMC
| – | – |
-20,972
| Closed | -$1.86M |
|
168
Donaldson
DCI
$9.28B
| – | – |
-11,848
| Closed | -$795K |
|
169
Incyte
INCY
$17.1B
| – | – |
-5,042
| Closed | -$305K |
|
170
Lantheus
LNTH
$3.71B
| – | – |
-4,329
| Closed | -$423K |
|
171
Oric Pharmaceuticals
ORIC
$1.04B
| – | – |
-40,934
| Closed | -$228K |
|
172
Bio-Techne
TECH
$8.18B
| – | – |
-11,252
| Closed | -$660K |
|
173
Teradyne
TER
$18.7B
| – | – |
-13,611
| Closed | -$1.12M |
|
174
WESCO International
WCC
$10.6B
| – | – |
-24,991
| Closed | -$3.88M |
|
175
Xenon Pharmaceuticals
XENE
$2.97B
| – | – |
-6,111
| Closed | -$205K |
|